In addition to assisting with administrative and legal resources to help bring technology to the marketplace, Center for Medical Innovation programs help with monetary resources.
Jump to topic
Potential Funding Opportunities
Bioadvance provides funding to start-up life science companies in southeastern Pennsylvania through its $20 million Greenhouse Fund. Investments are made in therapeutics, devices, diagnostics and platform technologies focused on human health.
Ben Franklin Technology Partners provides early stage technology funding and business support services to emerging tech-based start-ups and existing manufacturers in a 32-county footprint.
Life Science Greenhouse of Central Pennsylvania is a public/private venture whose mission is to commercialize bio-science technologies. It provides direct early-stage investment, targeted business development services and connections to strategic partners.
Innovation Partnership is a consortium of economic development and business assistance organizations located throughout the Commonwealth of Pennsylvania. Its goal is to help early-stage technology companies in Pennsylvania secure federal funding opportunities through SBIR/STTR Awards.
The Fund for Innovation Award is a proof-of-concept award program with up to $75,000 available to enable Penn State investigators to further develop a commercializable technology based upon Penn State intellectual property.
The aim of the Science Center QED Award Program is to provide comprehensive guidance and development to research that is working to achieve proof of concept prior to potential formation of a company. The QED program awards up to $200,000 to fund winning projects.
Science Center Phase 1 Ventures (P1V) works with “long-horizon” intellectual property and leverages the Science Center’s network of experienced entrepreneurs along with corporate and product-development professionals to strategically contribute expertise to your commercialization process. P1V contributes up to $450,000 of direct financing and helps obtain public and private funding.
Science Center Digital Health Accelerator (DHA) helps guide innovations ready to transition from research and development to sales by providing funding, collaborative workspace, professional mentorship and introductions to key healthcare stakeholders and investors. Participants are accelerated from prototype development to customer acquisition.
Kerafast is an e-commerce partner that provides cutting edge research tools of life science laboratories. The Center can help investigators work with Kerafast to list unique reagents, biologics and compounds from their laboratory on the investigator’s Annexe and receive a royalty from the sales.